Biogen Idec to Present on Best Practices for Leveraging Quality and Regulatory Compliance Management Software on Apple iPads
20 Marzo 2014 - 1:58PM
Marketwired
Biogen Idec to Present on Best Practices for Leveraging Quality and
Regulatory Compliance Management Software on Apple iPads
QUMAS to Host Live Webinar on March 25th
JERSEY CITY, NJ--(Marketwired - Mar 20, 2014) - QUMAS, an
Accelrys company (NASDAQ: ACCL), today announced that it will host
a live, complimentary webinar highlighting how to save time, money,
and materials and how to increase compliance across Manufacturing
by leveraging QUMAS Quality and Regulatory Compliance Management
Software on Apple iPads. The webinar will offer expert advice from
Gregory Chua, Senior Manufacturing Support Associate at Biogen Idec
and Murtuza Vasowalla, Director of Global Solutions Consulting at
QUMAS.
The webinar will detail how industry leader Biogen Idec has
transformed its manufacturing operations by replacing a system that
utilized manual processes and paper documents with an electronic
solution for managing quality and compliance.
This one-hour webinar will be held on Tuesday, March 25, from
12:00pm ET to 1:00pm ET and will cover:
- Review of old paper methods
- Piloting of devices
- User acceptance / feedback
- Implementation plan
- On-going enhancements
- Demonstration
For more information and to register for the webinar, visit
http://www.qumas.com/webinars/upcoming . The event will also be
recorded and available for on-demand viewing at
http://www.qumas.com.
About QUMAS
QUMAS is the leader in Enterprise Compliance Solutions with more
than 270 global customer deployments and two decades of experience
helping companies in highly regulated industries. QUMAS is a Gold
Microsoft Partner and provides the QUMAS Compliance Platform on
SharePoint 2010, Documentum, Oracle or SQL. For more information,
visit www.qumas.com.
About Accelrys
QUMAS is an Accelrys company. Accelrys (NASDAQ: ACCL), a leading
provider of scientific innovation lifecycle management software,
supports industries and organizations that rely on scientific
innovation to differentiate themselves. The industry-leading
Accelrys Enterprise Platform provides a broad, flexible scientific
foundation optimized to integrate the diversity of science,
experimental processes and information requirements across the
research, development, QA/QC and manufacturing phases of product
development. Accelrys offers capabilities in scientific data
management, modeling and simulation, research informatics,
laboratory informatics, enterprise quality management,
environmental health & safety and operations intelligence for
customers in science-driven industries. Using Accelrys technology,
scientific innovators can access, organize, analyze and share data
in unprecedented ways across the research, laboratory and
manufacturing continuum, ultimately enhancing innovation, improving
productivity and compliance, reducing costs and accelerating
product development from research to manufacturing.
Accelrys solutions are used by more than 2,000 customers in the
pharmaceutical, biotechnology, energy, chemicals, aerospace,
consumer packaged goods and industrial products industries.
Headquartered in San Diego, Calif., Accelrys employs approximately
225 full-time PhD scientists. For more information about Accelrys,
visit www.accelrys.com.
All trade names, trademarks, and service marks are rightful
property of their respective owners.
MEDIA CONTACT: Caoimhe Kiely VP Marketing QUMAS +353 21 4915100
Email Contact www.qumas.com
Grafico Azioni Accelrys, Inc. (MM) (NASDAQ:ACCL)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Accelrys, Inc. (MM) (NASDAQ:ACCL)
Storico
Da Giu 2023 a Giu 2024